NO883299D0 - Epipodofyllotoksinglukosid-4'-fosfatderivater. - Google Patents

Epipodofyllotoksinglukosid-4'-fosfatderivater.

Info

Publication number
NO883299D0
NO883299D0 NO883299A NO883299A NO883299D0 NO 883299 D0 NO883299 D0 NO 883299D0 NO 883299 A NO883299 A NO 883299A NO 883299 A NO883299 A NO 883299A NO 883299 D0 NO883299 D0 NO 883299D0
Authority
NO
Norway
Prior art keywords
epipodofyllotoksinglukosid
phosphate derivatives
phosphate
derivatives
Prior art date
Application number
NO883299A
Other languages
English (en)
Other versions
NO883299L (no
NO170284B (no
NO170284C (no
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO883299D0 publication Critical patent/NO883299D0/no
Publication of NO883299L publication Critical patent/NO883299L/no
Priority to NO920277A priority Critical patent/NO920277D0/no
Priority to NO920665A priority patent/NO172440C/no
Publication of NO170284B publication Critical patent/NO170284B/no
Publication of NO170284C publication Critical patent/NO170284C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
NO883299A 1987-08-04 1988-07-26 Analogifremgangsmaate til fremstilling av farmakologisk aktive 4'-fo sfatderivater av 4'-demetylepipodofyllotoksinglukosider NO170284C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO920277A NO920277D0 (no) 1987-08-04 1992-01-22 Kjemisk forbindelse og fremgangsmaate til fremstilling derav, samt anvendelse av forbindelsen
NO920665A NO172440C (no) 1987-08-04 1992-02-20 Kjemisk forbindelse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (4)

Publication Number Publication Date
NO883299D0 true NO883299D0 (no) 1988-07-26
NO883299L NO883299L (no) 1989-02-24
NO170284B NO170284B (no) 1992-06-22
NO170284C NO170284C (no) 1992-09-30

Family

ID=26765636

Family Applications (4)

Application Number Title Priority Date Filing Date
NO883299A NO170284C (no) 1987-08-04 1988-07-26 Analogifremgangsmaate til fremstilling av farmakologisk aktive 4'-fo sfatderivater av 4'-demetylepipodofyllotoksinglukosider
NO920277A NO920277D0 (no) 1987-08-04 1992-01-22 Kjemisk forbindelse og fremgangsmaate til fremstilling derav, samt anvendelse av forbindelsen
NO920665A NO172440C (no) 1987-08-04 1992-02-20 Kjemisk forbindelse
NO1998002C NO1998002I1 (no) 1987-08-04 1998-01-14 Etoposide-fosfat

Family Applications After (3)

Application Number Title Priority Date Filing Date
NO920277A NO920277D0 (no) 1987-08-04 1992-01-22 Kjemisk forbindelse og fremgangsmaate til fremstilling derav, samt anvendelse av forbindelsen
NO920665A NO172440C (no) 1987-08-04 1992-02-20 Kjemisk forbindelse
NO1998002C NO1998002I1 (no) 1987-08-04 1998-01-14 Etoposide-fosfat

Country Status (34)

Country Link
US (3) US4904768A (no)
JP (1) JPH0699465B2 (no)
KR (1) KR900006230B1 (no)
CN (1) CN1027169C (no)
AT (1) AT398974B (no)
BE (1) BE1002982A4 (no)
CA (1) CA1310637C (no)
CH (1) CH676716A5 (no)
CY (1) CY1625A (no)
CZ (1) CZ286893B6 (no)
DD (2) DD299067A5 (no)
DE (1) DE3826562A1 (no)
DK (2) DK169344B1 (no)
ES (1) ES2010775A6 (no)
FI (1) FI87790C (no)
FR (1) FR2622193B1 (no)
GB (1) GB2207674B (no)
GR (1) GR1000490B (no)
HK (1) HK6392A (no)
HU (3) HU208147B (no)
IE (1) IE61040B1 (no)
IL (1) IL87290A (no)
IT (1) IT1226825B (no)
LU (2) LU87290A1 (no)
MX (1) MX173843B (no)
MY (1) MY104321A (no)
NL (2) NL192683C (no)
NO (4) NO170284C (no)
NZ (1) NZ225615A (no)
PT (1) PT88186B (no)
SE (1) SE502214C2 (no)
SG (1) SG101291G (no)
SK (1) SK279325B6 (no)
YU (3) YU143688A (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (no) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JPH07632B2 (ja) * 1991-12-23 1995-01-11 ブリストル−マイヤーズ スクイブ カンパニー エトポシド４’−ホスフェート二ナトリウム塩の安定な六水和物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
EP0835303A4 (en) * 1995-06-07 2000-09-13 Univ Jefferson ANTIFUNGAL AGENTS AND THEIR IDENTIFICATION AND UTILIZATION METHODS
IL125895A (en) 1996-04-01 2001-09-13 Epix Medical Inc Use of an image-enhancing moiety in the preparation of a bioactivated nmr or optical imaging contrast agent from a prodrug
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
WO2003035661A1 (en) * 2001-10-26 2003-05-01 Centre National De La Recherche Scientifique Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
EP2269656B1 (en) 2002-07-15 2014-08-20 Board Of Regents, The University Of Texas Selected antibodies binding to aminophospholipids and their use in treatment, such as cancer
JP4903036B2 (ja) * 2003-01-06 2012-03-21 アンジオケム・インコーポレーテッド 血液脳関門を通過する担体としてのアプロチニンおよび類似体
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
DK2360258T3 (en) * 2005-02-18 2015-01-12 Angiochem Inc Aprotininpolypeptider to transport a compound of blood-brain-barrier
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
EP1907009A4 (en) * 2005-07-15 2009-09-02 Angiochem Inc USE OF APROTININ POLYPEPTIDES AS CARRIER IN PHARMACEUTICAL CONJUGATES
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8263644B2 (en) * 2007-09-13 2012-09-11 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
WO2009060198A1 (en) 2007-11-09 2009-05-14 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
ES2437595T3 (es) 2007-12-20 2014-01-13 Novartis Ag Derivados de tiazol usados como inhibidores de la PI 3 quinasa
DK2279008T3 (en) * 2008-04-18 2019-04-29 Angiochem Inc PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED PROCEDURES FOR PREPARATION AND USE
CN102245642A (zh) 2008-10-15 2011-11-16 安吉奥开米公司 Glp-1激动剂的结合物及其用途
RU2531591C2 (ru) 2008-10-15 2014-10-20 Ангиокем Инк. Конъюгаты этопозида и доксорубицина для доставки лекарственных средств
AU2009322043A1 (en) * 2008-12-05 2011-07-07 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
BRPI0922611A2 (pt) 2008-12-17 2018-11-06 Angiochem Inc inibidores de metaloproteína de matriz de membrana tipo 1 e usos dos mesmos
CA2759129C (en) 2009-04-20 2018-12-11 Angiochem Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
US9161988B2 (en) 2009-07-02 2015-10-20 Angiochem Inc. Multimeric peptide conjugates and uses thereof
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
BR112012019635A2 (pt) 2010-02-22 2016-05-03 Hoffmann La Roche compostos inibidores de pirido[3,2-d] pirimidina pi3k delta e métodos de uso
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
US8987257B2 (en) 2011-01-31 2015-03-24 Novartis Ag Heterocyclic derivatives
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
MX340452B (es) 2011-10-28 2016-07-08 Novartis Ag Novedosos derivados de purina y su uso en el tratamiento de enfermedades.
WO2013085922A1 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
KR20150009540A (ko) 2012-05-16 2015-01-26 노파르티스 아게 Pi-3 키나제 억제제에 대한 투여 요법
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
CN105979947A (zh) 2013-12-06 2016-09-28 诺华股份有限公司 α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose
RU2018119085A (ru) 2015-11-02 2019-12-04 Новартис Аг Схема введения ингибитора фосфатидилинозитол-3-киназы
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (no) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH481097A (de) * 1966-12-13 1969-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE3374317D1 (en) * 1982-11-26 1987-12-10 Nippon Kayaku Kk Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
HUT47303A (en) 1989-02-28
CZ541288A3 (cs) 1999-12-15
IE61040B1 (en) 1994-09-07
NO883299L (no) 1989-02-24
HU202547B (en) 1991-03-28
SK541288A3 (en) 1998-10-07
KR900006230B1 (ko) 1990-08-27
NO172440B (no) 1993-04-13
SE502214C2 (sv) 1995-09-18
CN1061225A (zh) 1992-05-20
NO920665D0 (no) 1992-02-20
US4904768A (en) 1990-02-27
KR890003790A (ko) 1989-04-18
CY1625A (en) 1992-07-10
NL970042I2 (no) 2005-06-01
NL8801934A (nl) 1989-03-01
DD274423A5 (de) 1989-12-20
LU87290A1 (fr) 1990-02-07
PT88186A (pt) 1989-06-30
SG101291G (en) 1992-01-17
MX9202851A (es) 1992-06-30
AU2030688A (en) 1989-06-08
GB2207674A (en) 1989-02-08
FR2622193A1 (fr) 1989-04-28
JPH0699465B2 (ja) 1994-12-07
MX173843B (es) 1994-03-30
ES2010775A6 (es) 1989-12-01
GR880100512A (en) 1989-05-25
YU143688A (en) 1990-04-30
MY104321A (en) 1994-03-31
CH676716A5 (no) 1991-02-28
NL970042I1 (nl) 1998-03-02
HU905862D0 (en) 1991-03-28
NO172440C (no) 1993-07-21
BE1002982A4 (fr) 1991-10-15
DD299067A5 (de) 1992-03-26
GR1000490B (el) 1992-07-30
FI87790B (fi) 1992-11-13
AT398974B (de) 1995-02-27
IT8821535A0 (it) 1988-07-28
NO170284B (no) 1992-06-22
CA1310637C (en) 1992-11-24
CN1027169C (zh) 1994-12-28
NZ225615A (en) 1991-06-25
GB2207674B (en) 1991-09-11
IL87290A (en) 1993-01-31
FI87790C (fi) 1993-02-25
SE8802815D0 (sv) 1988-08-03
DE3826562A1 (de) 1989-02-16
DK11992A (da) 1992-01-31
GB8818462D0 (en) 1988-09-07
IL87290A0 (en) 1989-01-31
NO920277L (no) 1989-02-24
NL192683C (nl) 1997-12-02
HK6392A (en) 1992-01-17
US5041424A (en) 1991-08-20
DE3826562C2 (no) 1993-04-08
FI883596A (fi) 1989-02-05
JPH01100188A (ja) 1989-04-18
IE882378L (en) 1989-02-04
LU90138I2 (fr) 1997-11-26
DK169344B1 (da) 1994-10-10
FR2622193B1 (fr) 1993-12-17
YU10390A (en) 1990-06-30
USRE35524E (en) 1997-06-03
DK434088A (da) 1989-02-05
YU10490A (en) 1990-06-30
PT88186B (pt) 1995-07-03
CZ286893B6 (cs) 2000-07-12
NO1998002I1 (no) 1998-01-14
NO920277D0 (no) 1992-01-22
HU208147B (en) 1993-08-30
NO170284C (no) 1992-09-30
DK434088D0 (da) 1988-08-03
IT1226825B (it) 1991-02-19
SK279325B6 (sk) 1998-10-07
SE8802815L (sv) 1989-02-05
FI883596A0 (fi) 1988-08-01
NO920665L (no) 1989-02-24
NL192683B (no) 1997-08-01
DK11992D0 (da) 1992-01-31
AU610619B2 (en) 1991-05-23
HU211960A9 (en) 1996-01-29
ATA195588A (de) 1994-07-15

Similar Documents

Publication Publication Date Title
NO883299D0 (no) Epipodofyllotoksinglukosid-4'-fosfatderivater.
FI880405A (fi) Adenosin-5'-karboxamidderivat.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
FI883963A0 (fi) Isoxazol- -karbolinderivat.
ATA320788A (de) 5,5-dimethyl-3-phenylvinyl-1-aminoalkoxy-iminocyclohex-2-enderivate
DK360888A (da) 3',4'-dinitrogen-substituerede epipodophyllotoxinglucosidderivater
DE3887281D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
NO883857D0 (no) 3'-demetoksyepipodofyllotoksin glukosid-derivater.
FI885785A (fi) Epipodofyllotoxinglukosid-4'-acylderivat.
DE3888097D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
DE3866371D1 (de) Diphenylaethylen-derivate.
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
DK161888D0 (da) Trioxabicyclo (2.2.2) octanderivater
DE3874027D1 (de) 1,3-dithiol-2-yliden-derivate.
DE3884482D1 (de) Thiapentanamid-derivate.
DE3868364D1 (de) Ucy-1003-derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.
DE3881146D1 (de) Thiazetidin-derivate.
IT8732835V0 (it) Cup-dispenser 02.
IT8732834V0 (it) Cup-dispenser 01.
FI871841A0 (fi) Evighetsmaskin/3.
FI871839A0 (fi) Evighetsmaskin/2.
FI871840A0 (fi) Evighetsmaskin/2.
MX9203634A (es) Derivados de pirocatecol 3,5-disubstituidos.

Legal Events

Date Code Title Description
MK1K Patent expired
MK1K Patent expired